Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science seminar

By Emilie Håkonsson LohseSoMe & Communication Coordinator

Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies focussing on their late-stage pipeline.

We have the pleasure of welcoming Bavarian Nordic, Gubra, ExpreS2ion Biotechnologies, Ascelia Pharma, Pharma Equity Group, Curasight, Hansa Biopharma, Qlife, Index Pharmaceuticals, NeoDynamics and BioPorto.

You can find the agenda for the seminar here.

Disclaimer: HC Andersen Capital receives payment from the attending companies for a Digital IR/corporate visibility agreement.

Stay up to date
Bavarian Nordic
Gubra
ExpreS2ion Biotech Holding
Ascelia Pharma
Pharma Equity Group
Curasight
BioPorto
Hansa Biopharma
Qlife Holding
Flerie
NeoDynamics

Recent videos

Roblon – Præsentation af årsregnskabet for 2024/25
06.01.2026, 10.00 Roblon
HCA Morgenbørs 06/01 - Europæiske futures indikerer at vi forlænger Santa Claus rally'et
06.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 05/01 - Positive europæiske futures og fokus på Novo Nordisk, Gubra og ISS
05.01.2026, 09.16 Novo Nordisk
Investor Day | Nov. 24, 2025
23.12.2025, 11.00 United Bankers
HCA Morgenbørs 23/12 - Flade futures og fokus på Novo Nordisk og Ørsted
23.12.2025, 09.27 Novo Nordisk
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.